Our new paper "Baseline Functional Performance Predicts Better Long-Term Self-Reported Physical Function After Auto-HSCT" is out in this J Clin Med special issue
https://t.co/FQEfNThk89
@JoseMGa95491291@lindseyjayneLA
Catch our new paper out now "Distinct Metabolomic Alterations Are Associated With Physical Function, Weight Loss, and Muscle Mass in Men With Cancer"
https://t.co/DlaUSqP70Q
Newly accepted paper alert!!
Bottom line: lower circulating LEAP2/ghrelin ratio may be protective against, or inversely associated with, cancer cachexia
@lindseyjayneLA@JoseMGa95491291@bestferren
https://t.co/kQlls6GRQa
Watch this associated video: Jose Garcia @JoseMGa95491291 and Haiming Kerr @bestferren describe how their study characterizes sarcopenia in aged mice: https://t.co/qecbR4exT6
@The_GarciaLabUW@UW
What’s the difference between age-related muscle loss and sarcopenia?
This study defines sarcopenia in one of the most common models of aging and identifies sex-specific differences. https://t.co/73zlT6R4PE
@The_GarciaLabUW@UW
Sex- and age-specific differences revealed by mouse sarcopenia models https://t.co/p9ww1qXSjl via @YouTube
presented by Drs. Jose Garcia and Haiming Kerr
@Sofy_Jar@The_GarciaLabUW@JoseMGa95491291@KateBUW I believe we were going to enroll PCa on the most recent trial, but we didn't launch our site before they finished enrollment. That one may not be published yet
@The_GarciaLabUW@lucas97caeiro@JoseMGa95491291 Interesting that Pre HOMA-IR predicts about half of the variability in delta %ASMI yet delta HOMA-IR was not correlated with the change in most outcomes. I wonder if anyone will suggest to you that patients with high IR should receive concomitant treatment with a GLP1 agonist?